Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2021 Oct 20;12:792330. doi: 10.3389/fphar.2021.792330

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Tianyu Zhai 1,2,3,, Xiaoyu Zhang 1,, Zhenyu Hei 1, Longyang Jin 4, Chao Han 5, Audrey Tsznam Ko 6, Xiaofeng Yu 7,*, Jiandong Wang 1,2,3,*
PMCID: PMC8564876  PMID: 34744756

In the published article, there was an error in the affiliations order. Affiliations 1 and 3 were interchanged, and the superscript numbers 1 and 3 in the authors’ affiliations list were updated accordingly.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES